Aequim Alternative Investments’s Bausch Health BHC Stock Holding History

Aequim Alternative Investments’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-30,000	Closed	-$243K	–	103
2023 Q1	$243K	Hold	30,000	–	–	0.01%	116
2022 Q4	$188K	Sell	30,000 -10,000	-25%	-$69.8K	0.01%	125
2022 Q3	$276K	Buy	40,000 +10,000	+33%	+$69.5K	0.01%	126
2022 Q2	$251K	Hold	30,000	–	–	0.01%	129
2022 Q1	$686K	Hold	30,000	–	–	0.02%	135
2021 Q4	$828K	Buy	+30,000	New	+$803K	0.03%	111
2021 Q2	–	Sell	-13,000	Closed	-$413K	–	107
2021 Q1	$413K	Hold	13,000	–	–	0.03%	88
2020 Q4	$270K	Hold	13,000	–	–	0.02%	83
2020 Q3	$202K	Hold	13,000	–	–	0.03%	69
2020 Q2	$238K	Hold	13,000	–	–	0.04%	64
2020 Q1	$202K	Buy	+13,000	New	+$313K	0.03%	59
2019 Q4	–	Sell	-33,300	Closed	-$728K	–	61
2019 Q3	$728K	Hold	33,300	–	–	0.15%	47
2019 Q2	$840K	Hold	33,300	–	–	0.24%	39
2019 Q1	$823K	Hold	33,300	–	–	0.29%	34
2018 Q4	$615K	Buy	+33,300	New	+$792K	0.31%	24

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Aequim Alternative Investments's BHC Position: Q2 2023 in Review

Aequim Alternative Investments sold out of Bausch Health (BHC) in Q2 2023, closing a stake of 30,000 shares — an estimated $243K sold.

Aequim Alternative Investments first reported a position in BHC in Q4 2018 and held it in 15 quarters. The position peaked at $840K in Q2 2019. 232 funds tracked by Wall St. Rank hold BHC as of Q2 2023.

Aequim Alternative Investments reported no remaining Bausch Health position as of Q2 2023 after selling out during the quarter.
Aequim Alternative Investments sold 30,000 Bausch Health shares in Q2 2023, an estimated $243K.
Aequim Alternative Investments first reported a position in Bausch Health in Q4 2018 and held it in 15 quarters.
Aequim Alternative Investments's Bausch Health position peaked at $840K in Q2 2019.
232 funds tracked by Wall St. Rank held Bausch Health as of Q2 2023.

Based on Aequim Alternative Investments's 13F filing for Q2 2023, filed 10 Aug 2023.